150 search results for: Pathophysiology

ATS 2024 | Type 2 Inflammation in the <b>Pathophysiology</b> of Asthma and COPD: What Is It and How Does It Impact Patients?
Congress
20
May
2024
Congress
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join experts Mario Castro, Nicola Hanania, and Stephanie Christenson for an educational symposium on the real-world impact of underlying type 2 inflammation on the patient burden of asthma and COPD.

Event Page Thumbnail
Congress
27
April
2026
Congress
ADVENT at CEORL-HNS 2026

Join Sanofi and Regeneron for an educational symposium on type 2 inflammation, patient characteristics predictive of disease recurrence, and emerging real-world evidence for biologics in CRSwNP.

ADVENT at IDS LearnSkin 2026
Congress
21
August
2026
Congress
IDS LearnSkin ADVENT Symposium

Join expert James Song for an educational symposium dispelling myths surrounding the inflammatory pathways and clinical features of atopic dermatitis.

Beyond the Skin: Cumulative Disease Burden in Children With Atopic Dermatitis
Dermatology
Beyond the Skin: Cumulative Disease Burden in Children With Atopic Dermatitis
expert video

Dr. Lara Wine Lee discusses the concept of cumulative life course impairment in AD, focusing on non-atopic comorbidities like vertical growth deficits and mental health impairment and how these might be preventable with early intervention at PeDRA 2025.

View more
Demystifying CPUO: Diagnosis and the Role of Type 2 Inflammation
Dermatology
Demystifying CPUO: Diagnosis and the Role of Type 2 Inflammation
expert video

Join Dr. Brian Kim in discussing the diagnosis of CPUO and the role of type 2 inflammation in disease pathophysiology.

View more
The Role of IL-4 and IL-13 in CSU
Dermatology
The Role of IL-4 and IL-13 in CSU
Infographic

The pathophysiology of chronic spontaneous urticaria (CSU) is complex and involves mast cell degranulation and elements of type 2 inflammation. Learn more about the role of mast cells, basophils, and type 2 inflammatory cells and cytokines involved in the pathophysiology of CSU.

View more
Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management
Dermatology
Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management
expert video

Professors Netchiporouk and Hawkes discuss the clinical features and pathophysiology of CSU, at EADV 2025.

View more
Skin Dyspigmentation In Prurigo Nodularis (PN)
Dermatology
Skin Dyspigmentation In Prurigo Nodularis (PN)
interactivity

This infographic illustrates the clinical manifestations, pathophysiology and impact on patients of skin dyspigmentation in Prurigo Nodularis.

View more
Beneath the Surface: How Autoimmunity and Predominantly Type 2 Inflammation Mediate BP
Dermatology
Beneath the Surface: How Autoimmunity and Predominantly Type 2 Inflammation Mediate BP
expert video

Professor Ulrike Raap reviews the pathophysiology of BP, highlighting the role of type 2 inflammation, in this video from EADV 2025

View more
The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis
Type 2 Inflammation
The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis
expert video

Join Dr. Shawn Kwatra in discussing the diverse clinical presentations of PN and the role of type 2 inflammation in disease pathogenesis.

View more
Chronic Spontaneous Urticaria Mechanism of Disease Animation
Dermatology
Chronic Spontaneous Urticaria Mechanism of Disease Animation
videoanimation

Explore the clinical presentation and pathophysiology of chronic spontaneous urticaria in this animated video. Learn about the complex mechanism of disease involving mast cell activation and the release of inflammatory mediators.

View more
Exploring the Potential Disease-Modifying Approaches in AD
Dermatology
Exploring the Potential Disease-Modifying Approaches in AD
interactivity

Explore the concept of disease modification in atopic dermatitis through this interactive infographic, which highlights potential considerations such as optimal sustained disease control, subclinical inflammation, the pathophysiology of AD, and atopic/non-atopic comorbidities.

View more